Bank Of Montreal Atara Biotherapeutics, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$4.69 - $9.84 $721,317 - $1.51 Million	153,799 New	153,799 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $925,352 - $1.38 Million	-77,177 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $994,811 - $1.28 Million	77,177 New	77,177 $1.28 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.